Rallis India Ltd pared its March quarter Q4FY26 losses to ₹15 crore over corresponding last quarter’s losses of ₹32 crore, on higher revenues. The company reported a 6 per cent growth in revenues during the Q4FY 26 at ₹456 crore (₹430 crore in Q4FY25) on higher volumes in crop care and seeds segments aided by pricing.
For FY26, Rallis reported a 47 per cent growth in net profit at ₹184 cr (125 crore) on higher revenues. Revenues for the year were up 9 per cent at ₹2897 crore (₹2663 crore). Tracking the results, Rallis India shares ended a tad higher on the NSE at ₹261.75 on Tuesday.
In a statement, Rallis said the Q4 performance reflected mixed demand conditions across crops and geographies, with lower pest pressure in certain crops impacting demand, while select segments continued to show resilience. The company recorded moderate growth during the quarter, supported by volume expansion and stable pricing.
During FY26, the Crop Care business grew by 8%, with the domestic formulations business delivering 5% growth driven by steady performance across key brands. The B2B exports business including Custom Synthesis Manufacturing (CSM) grew by 17%, supported by volume expansion in the International Business Division and improved realisations across key molecules. The Soil and Plant Health (SPH) segment delivered a growth of 8% despite regulatory challenges relating to Biostimulants, supported by focused product placement and demand generation initiatives, the company said. Seeds business grew by 15%, driven by strategic planning and execution amidst supply constraints and demand challenges in key crops like Cotton and Mustard.
Commenting on the performance, Dr Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said: “FY26 reflects our continued focus on strengthening the business through focused execution, portfolio expansion, and customer engagement. While demand conditions varied across the year, we remained focused on improving margins and driving growth across businesses. As we move forward, we will continue to build on our product portfolio, digital capabilities, and innovation pipeline to drive sustainable growth.”
In Crop Protection, the business launched two new insecticide products (Fiplam and Alstor), strengthening the product portfolio.
Published on April 28, 2026





























